SCHEMBL343203

SCHEMBL343203

CC(C)c1cccc(C(=O)O)c1C(=O)O.[KH]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 1/20 0.46
FABP4 P15090 1/20 0.46
LMNA P02545 2/20 0.43
HPGD P15428 2/20 0.43
CYP3A4 P08684 2/20 0.43
GABRA1 P14867 2/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
FAAH O00519 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.43
GABRB1 P18505 1/20 0.43
PTGS1 P23219 1/20 0.43
SLC6A2 P23975 1/20 0.43
HTR2C P28335 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
HTR2B P41595 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1356418 0.98 FABP3 (0.47) FABP3FABP4LMNAHPGDCYP3A4
Isopropyl Alcohol SCHEMBL8992570 0.94 FABP3 (0.44) FABP3FABP4LMNAHPGDCYP3A4
SCHEMBL22911 0.86 ALDH1A1 (0.44) LMNAHPGDCYP3A4CA1CA2
SCHEMBL29400459 0.86 ALDH1A1 (0.44) LMNAHPGDCYP3A4CA1CA2
SCHEMBL31090829 0.86 ALDH1A1 (0.44) LMNAHPGDCYP3A4CA1CA2
SCHEMBL6637397 0.86 FABP3 (0.59) FABP3FABP4LMNAHPGDCYP3A4
SCHEMBL27460996 0.85 FABP3 (0.43) FABP3FABP4LMNAHPGDCYP3A4
SCHEMBL1832023 0.85 LMNA (0.41) FABP3FABP4LMNAHPGDCYP3A4
SCHEMBL5549504 0.85 ALDH1A1 (0.43) LMNAHPGDCYP3A4CA1CA2
SCHEMBL10922833 0.85 ALDH1A1 (0.43) HPGDCYP3A4CA1CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120016152-A1 Process for the preparation of 4`-haloalkylbiphenyl-2-carboxylic acids SALTIGO GMBH (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016152-A1 Process for the preparation of 4`-haloalkylbiphenyl-2-carboxylic acids CYP4B1, HACL2, UGT1A4 FABP3 1511/4885FABP4 387/4885LMNA 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.